Cargando…

Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients

Vitiligo is a rare skin condition caused by an immune reaction. Vitiligo can occur anywhere on the body. This proposed explanation of vitiligo makes it clear that vitiligo is not linked to any other autoimmune diseases. The polymorphisms of some genes present in the immune system play a major functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Basher, Nosiba Suliman, Malik, Abdul, Aldakheel, Fahad, Chaudhary, Anis Ahmad, Rudayni, Hassan Ahmad, Alkholief, Musaed, Alshamsan, Aws
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324959/
https://www.ncbi.nlm.nih.gov/pubmed/34354433
http://dx.doi.org/10.1016/j.sjbs.2021.04.045
_version_ 1783731470453440512
author Basher, Nosiba Suliman
Malik, Abdul
Aldakheel, Fahad
Chaudhary, Anis Ahmad
Rudayni, Hassan Ahmad
Alkholief, Musaed
Alshamsan, Aws
author_facet Basher, Nosiba Suliman
Malik, Abdul
Aldakheel, Fahad
Chaudhary, Anis Ahmad
Rudayni, Hassan Ahmad
Alkholief, Musaed
Alshamsan, Aws
author_sort Basher, Nosiba Suliman
collection PubMed
description Vitiligo is a rare skin condition caused by an immune reaction. Vitiligo can occur anywhere on the body. This proposed explanation of vitiligo makes it clear that vitiligo is not linked to any other autoimmune diseases. The polymorphisms of some genes present in the immune system play a major function in susceptibility of vitiligo. Meta-analysis studies have shown that the Angiotensin converting enzyme (ACE) gene insertion and deletion polymorphism is closely associated with vitiligo in many ethnicities. The connection between ACE gene and vitiligo is connected through the auto immune diseases and there are no genetic polymorphism studies have been carried out with ACE gene with vitiligo in the Saudi population. Previous studies show that vitiligo patients are more likely to also have an autoimmune disorder. The current study aims to investigate the I/D polymorphism in the ACE gene with diagnosed patients with vitiligo subjects. This is a case-control study carried out in the Saudi population with 100 vitiligo cases and 100 healthy controls. Genotyping was performed through polymerase chain reaction followed by 3% agarose gel electrophoresis. Genotype and allele frequencies were carried out with genetic mode of inheritances. Statistical analysis was performed considering p < 0.05 as significant association. There was a substantial difference in allele frequency distribution between vitiligo patients and healthy controls (OR-1.70 (95%CI: 1.14–2.53); p = 0.008). Additionally, DD genotype (OR-4.71 (95%CI: 1.42–15.61); p = 0.008) and recessive model (OR-2.66 (95%CI: 1.41–5.02); p = 0.002) was strongly associated. Both dominant and co-dominant showed the negative association (p > 0.05) when compared between the vitiligo cases and controls. The correlation between age and genotyping was performed with Anova analysis and current study results confirmed the substantial link between 11 and 20 years (p = 0.01) and 31–40 years (p = 0.04) with the defined age groups. In conclusion, in Saudi populations, the ACE gene I/D polymorphism was identified as being correlated with vitiligo. This is the first study in Saudi Arabia to report the risk factors of vitiligo with the ACE gene polymorphism.
format Online
Article
Text
id pubmed-8324959
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83249592021-08-04 Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients Basher, Nosiba Suliman Malik, Abdul Aldakheel, Fahad Chaudhary, Anis Ahmad Rudayni, Hassan Ahmad Alkholief, Musaed Alshamsan, Aws Saudi J Biol Sci Original Article Vitiligo is a rare skin condition caused by an immune reaction. Vitiligo can occur anywhere on the body. This proposed explanation of vitiligo makes it clear that vitiligo is not linked to any other autoimmune diseases. The polymorphisms of some genes present in the immune system play a major function in susceptibility of vitiligo. Meta-analysis studies have shown that the Angiotensin converting enzyme (ACE) gene insertion and deletion polymorphism is closely associated with vitiligo in many ethnicities. The connection between ACE gene and vitiligo is connected through the auto immune diseases and there are no genetic polymorphism studies have been carried out with ACE gene with vitiligo in the Saudi population. Previous studies show that vitiligo patients are more likely to also have an autoimmune disorder. The current study aims to investigate the I/D polymorphism in the ACE gene with diagnosed patients with vitiligo subjects. This is a case-control study carried out in the Saudi population with 100 vitiligo cases and 100 healthy controls. Genotyping was performed through polymerase chain reaction followed by 3% agarose gel electrophoresis. Genotype and allele frequencies were carried out with genetic mode of inheritances. Statistical analysis was performed considering p < 0.05 as significant association. There was a substantial difference in allele frequency distribution between vitiligo patients and healthy controls (OR-1.70 (95%CI: 1.14–2.53); p = 0.008). Additionally, DD genotype (OR-4.71 (95%CI: 1.42–15.61); p = 0.008) and recessive model (OR-2.66 (95%CI: 1.41–5.02); p = 0.002) was strongly associated. Both dominant and co-dominant showed the negative association (p > 0.05) when compared between the vitiligo cases and controls. The correlation between age and genotyping was performed with Anova analysis and current study results confirmed the substantial link between 11 and 20 years (p = 0.01) and 31–40 years (p = 0.04) with the defined age groups. In conclusion, in Saudi populations, the ACE gene I/D polymorphism was identified as being correlated with vitiligo. This is the first study in Saudi Arabia to report the risk factors of vitiligo with the ACE gene polymorphism. Elsevier 2021-08 2021-04-24 /pmc/articles/PMC8324959/ /pubmed/34354433 http://dx.doi.org/10.1016/j.sjbs.2021.04.045 Text en © 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Basher, Nosiba Suliman
Malik, Abdul
Aldakheel, Fahad
Chaudhary, Anis Ahmad
Rudayni, Hassan Ahmad
Alkholief, Musaed
Alshamsan, Aws
Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title_full Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title_fullStr Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title_full_unstemmed Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title_short Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
title_sort deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324959/
https://www.ncbi.nlm.nih.gov/pubmed/34354433
http://dx.doi.org/10.1016/j.sjbs.2021.04.045
work_keys_str_mv AT bashernosibasuliman deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT malikabdul deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT aldakheelfahad deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT chaudharyanisahmad deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT rudaynihassanahmad deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT alkholiefmusaed deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients
AT alshamsanaws deleteriouseffectofangiotensinconvertingenzymegenepolymorphisminvitiligopatients